AZTRAzitra, Inc.

Partial data

—Mkt Cap: —P/E: —109d ago

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States…

Key Statistics

Company

Market Cap—

Enterprise Value-6.31M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-10.96M $

Revenue/Share—

Last Price—

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees13

CountryUS

SectorHealthcare

Industry—

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.40

PEG—

EV/EBITDA0.54

EV/Revenue—

P/S—

P/B0.32

EPS (TTM)-0.95

EPS (Forward)-0.52

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-288.21%

ROA-218.00%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-11.22M $

CapEx (TTM)186.06K $

FCF Margin—

FCF Yield—

Net Debt-9.71M $

Net Debt/EBITDA0.83

Balance Sheet

Debt/Equity0.11

Current Ratio6.94

Quick Ratio6.58

Book Value/Sh0.6470 USD

Cash/Share0.6210 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split15:100

Split DateAug 21, 2025

Analyst Consensus

Rating—

Target (Mean)0.7750 USD

Target Range0.5500 USD – 1.000 USD

# Analysts2

Ownership

Shares Out.16.19M

Float16.18M

Insiders28.48%

Institutions6.27%

Short Interest

Short Ratio0.1d

Short % Float0.58%

Short % Out.0.38%

Shares Short61.64K

Short (prev mo.)397.82K

Technical

SMA 500.2169 USD

SMA 2000.3481 USD

Beta-1.28

S&P 52W Chg20.90%

Avg Vol (30d)—

Avg Vol (10d)65.92M

Technical Indicators

RSI (14)48.1

MACD-0.0000

MACD Signal-0.0013

MACD Hist.+0.0012

BB Upper0.2385 USD

BB Middle0.2102 USD

BB Lower0.1820 USD

BB Width26.85%

ATR (14)0.0181 USD

Vol Ratio (20d)0.41x

AZTRAzitra, Inc.

Industry Peers

Key Statistics